Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2017 04:26 ET | Source: ALK Abello

ALK appoints Søren Jelert as new Chief Financial Officer

Copenhagen, 2017-11-03 09:26 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced the appointment of Søren Jelert as its new Chief Financial Officer (CFO) and...
November 03, 2017 03:23 ET | Source: ALK Abello

Release date of nine-month interim report (Q3) 2017 and audio cast

Copenhagen, 2017-11-03 08:23 CET (GLOBE NEWSWIRE) -- On Friday, 10 November 2017, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its interim report for the nine months ended 30...
November 03, 2017 03:23 ET | Source: ALK Abello

Dato for offentliggørelse af delårsrapport for første ni måneder (Q3) 2017 for ALK og webcast

København, 2017-11-03 08:23 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) offentliggør delårsrapport for første ni måneder (Q3) 2017 fredag den 10. november 2017. ALK...
October 12, 2017 16:43 ET | Source: ALK Abello

Meddelelse om ejerskab i ALK

København, 2017-10-12 22:43 CEST (GLOBE NEWSWIRE) -- I henhold til § 29 i Lov om værdipapirhandel m.v. har ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) modtaget meddelelse fra Jupiter Asset...
October 12, 2017 16:43 ET | Source: ALK Abello

Notification of ownership in ALK

Copenhagen, 2017-10-12 22:43 CEST (GLOBE NEWSWIRE) -- Pursuant to section 29 of the Danish Securities Trading Act, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) has received notification from...
September 27, 2017 03:00 ET | Source: ALK Abello

ALKs partner, Torii, opnår godkendelse af tabletvaccine mod japansk cedertræsallergi i Japan

København, 2017-09-27 09:00 CEST (GLOBE NEWSWIRE) -- CEDARCURE™ er den første tabletvaccine, der er godkendt i Japan til behandling af både voksne og børn. CEDARCURE™ fuldender...
September 27, 2017 03:00 ET | Source: ALK Abello

ALK’s partner, Torii, gains approval for Japanese cedar SLIT-tablet in Japan

Copenhagen, 2017-09-27 09:00 CEST (GLOBE NEWSWIRE) -- CEDARCURE™ is the first SLIT-tablet to be approved for both adult and paediatric use in Japan Joins the already launched...
September 21, 2017 13:39 ET | Source: ALK Abello

ALK acts on French injunction by accelerating investments in its quality system at the French manufacturing facility

Copenhagen, 2017-09-21 19:39 CEST (GLOBE NEWSWIRE) -- ALK’s 2017 full-year guidance remains unchanged. ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the French National...
September 21, 2017 13:39 ET | Source: ALK Abello

Fransk påbud får ALK til at fremrykke investeringer i selskabets kvalitetssystem på fransk fabrik

København, 2017-09-21 19:39 CEST (GLOBE NEWSWIRE) -- ALKs forventninger til regnskabsåret 2017 forbliver uændrede. ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddelte i dag, at de...
September 14, 2017 07:15 ET | Source: ALK Abello

Successful Phase III trial for ALK’s tree allergy SLIT-tablet

Copenhagen, 2017-09-14 13:15 CEST (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced the successful outcome of a pivotal Phase III clinical trial of its tree...